Literature DB >> 1929687

Long-term use of nicotine vs placebo gum.

J R Hughes1, S W Gust, R Keenan, J W Fenwick, K Skoog, S T Higgins.   

Abstract

Medical patients (n = 315) who wished to quit smoking were randomly assigned in a double-blind manner to receive either nicotine or placebo gum. Subjects were advised to stop gum use by 4 months. Among abstinent smokers, 46% of those receiving nicotine gum and 17% of those receiving placebo gum used the gum beyond the recommended 4-month period. By 10 months after cessation 17% of quitters receiving nicotine gum and 6% receiving placebo gum were still using gum. Gradual reduction of nicotine gum did not result in withdrawal and cessation of nicotine gum did not increase the probability of relapse to smoking or weight gain. We conclude that use of nicotine gum is due, in part, to the effects of nicotine; however, long-term use is uncommon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929687

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

1.  Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.

Authors:  S Shiffman; J R Hughes; J L Pillitteri; S L Burton
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

Review 2.  A review of smoking cessation interventions.

Authors:  Ashish Maseeh; Gagandeep Kwatra
Journal:  MedGenMed       Date:  2005-06-07

3.  Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products.

Authors:  Irina Stepanov; Steven G Carmella; Anna Briggs; Louise Hertsgaard; Bruce Lindgren; Dorothy Hatsukami; Stephen S Hecht
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

4.  Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers.

Authors:  Michael D Stein; Bradley J Anderson; Raymond Niaura
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

5.  Physical dependence on nicotine gum: effect of duration of use.

Authors:  D Hatsukami; M Huber; A Callies; K Skoog
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

Review 7.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

Review 8.  Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?

Authors:  Tammy Harris Sims; Michael C Fiore
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 9.  Risk-benefit assessment of nicotine preparations in smoking cessation.

Authors:  J R Hughes
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

10.  Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial.

Authors:  Nicola Lindson; Paul Aveyard; Jackie T Ingram; Jennie Inglis; Jane Beach; Robert West; Susan Michie
Journal:  Trials       Date:  2009-08-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.